Lensar (LNSR) Non Operating Interest Expenses (2019 - 2020)
Lensar's (LNSR) quarterly Non Operating Interest Expenses came in at $65000.0 in Q3 2020, down 86.84% year-over-year from $494000.0 in Q4 2019, and down 90.31% quarter-over-quarter from $671000.0 in Q2 2020.
Powered by 
Analysis
Lensar (LNSR) Non Operating Interest Expenses (2019 - 2020) Analysis & Trends
Lensar (LNSR) has reported Non Operating Interest Expenses for 2 consecutive years, with $65000.0 the latest figure, recorded in Q3 2020.
- On a quarterly basis, Non Operating Interest Expenses fell 86.84% year-over-year to $65000.0 in Q3 2020; TTM through Jun 2021 was $65000.0, a 97.2% decrease from a year earlier, with the FY2020 full-year figure at $1.3 million, down 33.03% from the prior year.
- Non Operating Interest Expenses was $65000.0 for Q3 2020 at Lensar, down from $671000.0 in the prior quarter.
- Over five years, Non Operating Interest Expenses peaked at $671000.0 in Q2 2020 and troughed at $65000.0 in Q3 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.57 Bn | 178.97 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 124.13 Bn | 118.91 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.29 Bn | 109.47 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 104.60 Bn | 101.12 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.50 Bn | 65.97 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.97 Bn | 32.51 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.23 Bn | 30.29 Bn | 830.00 Mn | - |
| 9 | Steris | 21.16 Bn | 20.68 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Lensar | 103.29 Mn | 89.73 Mn | 9.78 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 65,000.00 |
| Jun 30, 2020 | 671,000.00 |
| Mar 31, 2020 | 604,000.00 |
| Dec 31, 2019 | 554,000.00 |
| Sep 30, 2019 | 494,000.00 |